Dr. Eric Donnenfeld performed Long Island’s first iDose TR procedure on August 15, 2024, revolutionizing glaucoma treatment with continuous medication delivery. This achievement underscores OCLI Vision’s leadership in innovative eye care.
GARDEN CITY, N.Y., Sept. 3, 2024 /PRNewswire-PRWeb/ — OCLI Vision is proud to announce a groundbreaking achievement at one of its Long Island locations. Thursday, August 15th, Dr. Eric Donnenfeld, MD, one of the nation’s top ophthalmologists, accomplished a historic milestone by performing Long Island’s very first iDose TR procedure.
Dr.Donnenfeld is a trailblazer in ophthalmology, renowned for his expertise in refractive, cornea, and cataract surgery. His exceptional skill has earned him the title of Newsweek’s top ophthalmologist in the United States for three years running (2021, 2022, 2023). His reputation as a leading authority in eye care is firmly established.
The iDose TR procedure marks a revolutionary leap in treating Open-Angle Glaucoma (OAG) and Ocular Hypertension (OHT). This cutting-edge treatment involves a unique, long-duration, anchored intracameral therapy that continuously delivers prostaglandin analogs directly into the eye’s anterior chamber. This steady medication release ensures superior, long-term control of intraocular pressure (IOP), offering patients a groundbreaking alternative to traditional treatments.
This pioneering procedure not only highlights OCLI Vision’s dedication to incorporating the latest advancements in eye care but also underscores Dr. Donnenfeld’s role in pushing the boundaries of ophthalmologic innovation. The successful execution of iDose TR reinforces OCLI Vision’s reputation as a leader in cutting-edge eye care.
For those eager to learn more about this revolutionary procedure and explore how it might benefit your eye health, please contact OCLI Vision at 833-509-6254 for more information.
About OCLI Vision
Founded in 1997, OCLI Vision (https://www.ocli.net) is one of the leading ophthalmology and optometry practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania, and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care, who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.
According to the Lymphatic Education & Research Network, an estimated 1 in every 1,000 people in the United States suffers from lymphedema. Among cancer survivors, the prevalence is higher, with about 20-40% of breast cancer survivors developing lymphedema, particularly post-surgery and radiation therapy. The economic impact of lymphedema includes direct medical costs for treatment and indirect costs such as lost productivity.
Dr. Andrew Elkwood, practicing surgeon and founder of The Institute for Advanced Reconstruction stated, “Dr. Dayan’s arrival marks a significant milestone for patients seeking advanced treatment options for lymphedema, a condition that poses significant challenges for individuals, particularly those undergoing breast cancer treatment. While lifelong compression and physiotherapy have been standard treatment approaches, many patients continue to experience disease progression despite their compliance. Dr. Dayan’s expertise offers hope for those in need of alternative solutions.”
“Joining The Institute for Advanced Reconstruction and establishing The Institute for Lymphatic Surgery and Innovation will offer patients suffering from lymphedema a new option for care that will feature state-of-the-art techniques with use of some of the newest technology and instruments in the world,” said Dr. Dayan. “Our established presence in NJ and partnerships with some of the most well-known reconstructive surgery practices throughout the United States will offer patients new innovative options for care of this prevalent disease.”
In addition to assembling a clinical team of experts in lymphatic surgery, The Institute for Lymphatic Surgery and Innovation purchased a Mitaka microscope, the highest resolution microscope available designed specifically for intricate procedures such as lymphatic surgery, allowing surgeons to visualize and operate on lymphatic vessels with exceptional clarity and precision. Other advanced instruments being used at The Institute include an ultra-high frequency ultrasound and ICG lymphangiography, further enhancing specific care for patients.
Dr. Dayan began seeing patients from around the world and performed the first lymphatic surgery at The Valley Hospital on August 16th. The surgery included immediate lymphatic reconstruction using lymphovenous bypass to reduce the risk of lymphedema at the time of axillary dissection.
Dr. Dayan’s surgical contributions extend to several areas. For breast reconstruction, he utilizes techniques that use the patient’s own tissue, including DIEP, GAP, and PAP flaps. Notably, Dr. Dayan pioneered the DUG flap technique, expanding treatment options for a broader range of patients. Dr. Dayan has extensive microsurgical experience utilizing a range of techniques to reanimate the face due to facial paralysis from conditions like parotid cancer, acoustic neuroma, Bell’s Palsy and developmental facial paralysis. He is an expert in surgical planning that utilizes nerve transfers, grafts and muscle transfers to restore function and quality of life to patients with facial paralysis.
Prior to joining The Institute, Dr. Dayan spent 10 years at Memorial Sloan Kettering Cancer Center, where he established lymphatic surgery and facial nerve programs, and honed his skills through an esteemed fellowship in advanced microsurgical reconstruction at the renowned Chang Gung Memorial Hospital in Taiwan.
Dr. Dayan was honored with the prestigious Godina Traveling Fellowship in recognition of his significant contributions to microsurgery. With over 100 peer-reviewed publications, numerous book chapters, and his recent editorial work on a textbook dedicated to lymphedema, Dr. Dayan continues to advance knowledge and understanding in his areas of expertise. He serves as the founding president of the American Society for Lymphatic Surgery and has been a dedicated board member of the Lymphatic Education and Research Network for over a decade.
Dr. Dayan has been recognized with several prestigious awards, including Castle Connolly’s America’s Top Doctor in 2024, Top Doctor in the New York Metro Area in 2023, and national and regional Top Doctor in New York Magazine from 2016 to 2020.
Dr. Dayan is currently seeing patients in Westwood, NJ. For more information or to schedule a consultation, please visit www.AdvancedReconstruction.com or call 833-598-2417.
About the Institute for Advanced Reconstruction
The Institute specializes in advanced reconstructive surgery and innovative healthcare solutions. Our expert team addresses numerous conditions, ranging from cancer-related diseases and hand trauma to peripheral nerve disorders. Based on an academic, collaborative care approach, we bring together the specialized training and expertise of the country’s finest surgeons and medical teams to deliver transformative results.
With clinics across the country, The Institute attracts patients from around the globe by providing access to the world’s most accomplished doctors, state-of-the-art surgical techniques, and advanced medical technologies. We are dedicated to cutting-edge research and advancing medical frontiers, persistently raising the bar on what is possible in reconstructive healthcare.
“We are excited to partner with CellEx,” said Alain Alonso, vice president of sales at MatTek. “This licensing deal not only signifies our entry into one of the world’s largest and most dynamic markets but also aligns with our mission to innovate and provide superior 3D models globally. We are confident that this collaboration will create significant value for our customers in China.”
MatTek tissues are currently produced in laboratories in the United States and Slovakia and are shipped from those locations worldwide. MatTek’s partnership with CellEx will allow tissues to be produced within China, serving an entirely new market of customers eager to utilize this technology.
“We are so honored to collaborate with MatTek,” said E (Robert) Zhao, chief executive officer of CellEx. “This licensing deal makes up for the huge demand gap of all kinds of customers in the Chinese market for a long time, as well as promoting the integration of Chinese tissue engineering technology with international standards.”
MatTek and CellEx share a commitment to expanding the global reach of lab-grown microtissue technology. The collaboration will provide access to researchers in China and empower them to choose human-relevant research and testing solutions. MatTek and CellEx anticipate that the collaboration will begin to produce human tissues within the next six months, with a series of new product launches and market expansions planned.
Honorees included health care professionals, caregivers, people with PH and PHA support group leaders. See the full list of honorees below.
Julie Hendry Memorial Scholarship Award: Adriana C. Mares
Named for PHA’s first full-time non-patient volunteer, this award supports a non-patient volunteer who advances PHA’s mission. Mares, a student researcher at Yale, received this award for her leadership in the El Paso PHighters support group and her contributions to cardiovascular medicine. She has authored over 25 peer-reviewed journal articles and founded the Institute of Cardiology at El Paso, focusing on PH and congenital heart disease.
The Rino Aldrighetti Leadership Award: Anton Morkin
Recognizes exceptional leadership in advancing PHA’s vision of a world without PH. Morkin was honored for co-founding TBX4Life, a nonprofit supporting people with TBX4 Syndrome and heritable PAH. Motivated by his son’s diagnosis, Morkin’s work has united families from over 10 countries and established a global scientific consortium of more than 70 members. His efforts have driven cross-disciplinary research focused on discovering new treatments.
The PHA Philanthropy Award: Ed and Judith Simpson
Recognizes outstanding charitable commitment and generosity that encourages financial support for PHA. Judy Simpson founded the organization that became PHA in 1991, along with her sister Pat Paton, Teresa Knazik, Dorothy Olson, and their husbands. The Simpsons have been long-standing supporters of PHA, contributing their time, talents and resources since the organization’s inception.
Outstanding Physician: Jean M. Elwing, MD
Recognizes notable service to PHA through clinical care, research, education and advocacy for PH patients. Elwing, director of the pulmonary hypertension program at the University of Cincinnati, received this award for her leadership in pulmonary vascular disease and PH research. She has been an influential figure in advancing clinical care and improving outcomes for those affected by PH.
Outstanding Allied Health Professional: Sandra Lombardi, RN
Recognizes contributions to the PH community through raising awareness, advocacy and compassionate care. Lombardi received this award for dedicating 25 of her 30 years in pulmonary and critical care medicine to pulmonary arterial hypertension. She has educated patients and providers on PAH medications and coordinated clinical trials, all while leading a thriving support group for 25 years, which she considers her proudest achievement.
Outstanding Young PH Citizen Award: Cash Harpp
Honors a person with PH, aged 30 or under, for their dedication to the PH community through awareness, advocacy and service. Harpp has shown remarkable resilience while living with idiopathic PAH. He actively participates in clinical trials and advocates for other children with PH.
Outstanding PH Citizen: Michelle Sweitzer
Recognizes a person with PH for their exemplary dedication to the PH community. Sweitzer has spent more than 40 years advocating and raising awareness, driven by the loss of her brother and father to PH. Through a family-run golf tournament, she has raised over $400,000 for research and remains a passionate advocate following her own PH diagnosis in 2017.
Outstanding Caregiver: Cindy Warnberg
Recognizes a non-patient caregiver’s dedication to improving the quality of life for a loved one with PH. After her daughter Chelsea’s PAH diagnosis, Warnberg acted by organizing the Puttin’ PHore Poots golf tournament. Under her leadership, the event has grown steadily, raising more than $200,000 for PH research and awareness.
Outstanding PHA Support Group Leader Award: Sophia I. Esteves
Recognizes a support group leader who creates a welcoming environment and champions awareness and advocacy. Esteves earned the recognition for her leadership of the San Antonio, Texas, support group. A patient advocate for more than 22 years, Esteves also serves as a spokesperson for Johnson & Johnson’s Breathe In, Speak Out campaign, using her platform to inspire and guide those facing the challenges of PH.
About the Pulmonary Hypertension Association
Headquartered in Washington, D.C., the Pulmonary Hypertension Association is the oldest and largest nonprofit patient association dedicated to the pulmonary hypertension community. Pulmonary hypertension is a rare, chronic and life-threatening condition affecting the lungs for which no cure currently exists. PHA’s mission is to extend and improve the lives of those affected by PH.
To achieve this mission, PHA engages people with PH and their families, caregivers, health care professionals, and researchers worldwide to work together to advocate for the PH community, provide support to patients, caregivers and families, offer up- to-date education and information on PH, improve quality patient care, and fund and promote research. For more information, visit PHAssociation.org or connect with PHA on X/Twitter, Instagram, Facebook and LinkedIn.
Erica Bent of Desert Oasis Healthcare Home Health is honored this month due to her continuous care coordination and resourcefulness
DALLAS, Sept. 3, 2024 /PRNewswire-PRWeb/ — Homecare Homebase SM (HCHB), the leading software provider for home-based care, is happy to name Erica Bent, RN Case Manager at Desert Oasis Healthcare Home Health (HPN), as the September 2024 Gold Standard Award winner.
“Erica is an exceptional manager who consistently manages her caseload, completes same-day documentation and ensures continuity of care,” said Brian Michaelsen, MSW, administrator, operations at Desert Oasis Healthcare. “A PointCare star and valuable peer resource, she provides training on system navigation and supply requisitioning and fully integrates HCHB into her patient care practice.”
The Gold Standard Award celebrates outstanding home-based caregivers who utilize HCHB to deliver exceptional patient care. Nominees are submitted by their agency leaders and meticulously chosen by the HCHB team for their expertise, enthusiasm, and steadfast dedication.
“I’ve been a nurse since 2011 and in Home Health since 2016, using HCHB,” said Erica. “What I love about Home Health is the one-on-one time with patients, allowing for uninterrupted care and education in their comfortable home setting, leading to better health outcomes. I’m honored to receive this award and look forward to continuing to provide thorough care for my patients.”
“Erica exemplifies the qualities we seek in a Gold Standard Award winner,” said Brandy Sparkman-Beierle, chief clinical officer at Homecare Homebase. “Her dedication to her patients, meticulous attention to detail, and unwavering commitment to care coordination make her an invaluable asset to Desert Oasis Healthcare Home Health and the broader home-based care community. Erica’s expertise in Homecare Homebase, coupled with her leadership in training and supporting her peers, showcases her ability to integrate best practices into patient care. She truly embodies the spirit of excellence in home health.” To learn more about these companies, visit hchb.com and mydohc.com.
About Homecare Homebase, LLC Founded by industry veterans in 1999, Homecare HomebaseSM (HCHB) is a Dallas-based software leader empowering exceptional home-based care through hosted, cloud-based technology solutions and administrative services. HCHB’s customized mobile solutions enable real-time, wireless data exchange and communication between field clinicians, physicians and office staff for better care, more accurate reporting and improved revenue cycle management. HCHB’s products and services streamline operations, simplify compliance and boost clinical and financial outcomes for home-based care agencies. Each year, over 200,000 HCHB users serve approximately 800,000 patients daily, resulting in over one hundred million visits. The company is part of the Hearst Health network. For more information, visit http://www.hchb.com or call us toll-free at 1-866-535-HCHB (4242).
About Hearst Health The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG,Homecare Homebase and MHK. Hearst also holds a minority interest in the precision medicine and oncology analytics company Aster Insights. Follow Hearst Health on X @HearstHealth and LinkedIn @Hearst-Health.
About Desert Oasis Healthcare Formed in 1981 as one of the first medical groups in the desert communities of southern California, Desert Oasis Healthcare (DOHC) continues to advance with changes in the healthcare market. DOHC provides primary and immediate care, home health, palliative care, clinical research studies and other services to more than 60,000 members/patients living in the greater Coachella Valley and the Morongo Basin of Riverside and San Bernardino counties. The multidisciplinary and comprehensive care programs of DOHC are committed to educating individuals on preventive health care in their daily lives, reflected in the DOHC motto, “Your Health. Your Life. Our Passion.” For more information, visit http://www.mydohc.com.
The Freedom Titan PCK Revision Knee System maintains the same advanced, clinically proven design as the Freedom PCK Revision Knee System, featuring progressive constraint kinematics, multi-radius femoral design, patented trapezoidal box, and titanium stems, augments and couplers. Titan PCK has a unique golden color on the femoral and tibial components from the titanium niobium nitride (TiNbN) coating produced by a physical vapor deposition (PVD) process. The strong TiNbN coating has been shown to block or significantly reduce the release of metal ions common in orthopedic joint replacement implants.
Titan PCK System demonstrates our ongoing pursuit of knee arthroplasty solutions that address needs in total joint replacement, especially the 10-15% of the population with metal sensitivity. Farzin Khaghani, Chief Commercial Officer, states “The FDA clearance of Freedom Titan PCK System further demonstrates our commitment to developing a strong product pipeline that broadens our portfolio, drives growth, and addresses the needs of a diverse patient population. We are thrilled to offer our distinct Titan knee portfolio to osteoarthritis patients dealing with challenges associated with metal sensitivity.”
Maxx Orthopedics has established a partnership with Unik Orthopedics (UNIKO) to offer personalized surgical instrument blocks for total knee arthroplasty.
UNIKO recently received FDA 510(k) clearance for PointCloud™ Knee Instrument intended for use in surgery to assist with intraoperative implant placement and as a guide for bony resections during total knee replacements. Preoperative MRI scans are obtained during the Pre-Op planning process and used to identify anatomic landmarks necessary for alignment and positioning of the implant during the procedure.
UNIKO PointCloud Knee Instruments (UKI) and the Vault System (web-based surgical planning tool) are compatible with the Freedom® Total Knee System. Combining the UNIKO PointCloud with our Quick Recovery Solutions (QRS®) platform, offers a perfect blend of complementary technologies and an efficient, cost-effective solution for ambulatory surgery centers and hospitals.
The PointCloud Knee Instruments allow surgeons to have patient-specific, CNC machined solid block (Acetal-C), single-use instruments during surgery. Surgeons will be able to precisely template PSI blocks during pre-operative planning and recommend patient-specific component sizing. “Dr. Kurtis Biggs (Naples, FL) recently performed the first Freedom Primary Knee procedure in the United States using the new UNIK Ortho PSI blocks. Our partnership with UNIKO should increase efficiency for total knee arthroplasty within outpatient surgery centers and hospitals. We are excited to offer QRS, Freedom Knee System, and PointCloud technologies together for the benefit of both patients and surgeons, states Anand Bala, Vice President of Product.
References
1. Serro et al. (2009) A Comparative Study of Titanium Nitrides, TiN, TiNbN and TiCN, as Coatings for Biomedical Applications. Surface & Coatings Technology 203 (2009), pp. 3701–3707
About Maxx Orthopedics, Inc.
Maxx Orthopedics, Inc. is the manufacturer of the Freedom Knee System, Libertas Total Hip System, and Quick Recovery Solutions (QRS). We develop and market innovative orthopedic medical devices with a focus on providing state-of-the-art implants and related solutions designed that best restore patient mobility, while accommodating lifestyle, anatomical and economic needs. Find out more at www.maxxortho.com and follow us on LinkedIn, X, Instagram, and Facebook.
As an internist, Dr. Kalva can treat most medical disorders but has special interest in weight loss, cardiovascular health, cardiometabolic/metabolic syndrome, men’s health, integrative primary care, hypothyroidism, fatigue, aging, MTHFR/COMT genetic vulnerabilities, and much more. He has made it his life mission to heal people in a natural, integrative way without prescription drugs whenever possible so that patients can lead positive and active lives.
Dr. Kalva is accepting new patients. He is committed to providing care for the whole person by using innovative functional medicine services to help patients achieve a better level of health.
About National Integrated Health Associates
National Integrated Health Associates, NIHA, is a leading integrative and functional medicine and holistic dental center serving the Washington D.C., Maryland, and Virginia metropolitan area. Practitioners blend the best of conventional medicine and integrative medical therapies to help the body heal and achieve optimum wellness. Specialty lab and IV services, chiropractic care and detoxification therapies are offered on-site at our convenient integrative health center in Washington, D.C.https://nihadc.com
“My story is about people along the way who influenced me in ways that caused me to think differently about my atheism, to become interested in the Christian faith, to get some sense of who Jesus is and his call to come and follow him,” said Bock. “They shared their lives and prayed for me and became my friends. In the end, their stories became part of my story.”
Bock became an atheist in high school and studied philosophy as an undergraduate, including two years at the University of Vienna. A mystical encounter in a monastery in Germany and conversations with Catholic priests and laypeople caused him to rethink his views of God and religion. When he shifted to economics at Oxford and started his career, he continued to encounter people who talked to him about spirituality, Jesus of Nazareth, and the supernatural nature of the Christian walk. His journey from atheism to faith culminated during a dinner with friends when he was overwhelmed by the love of God and felt dramatically set free from the intellectual shackles of his atheism.
“Religious faith is a gift from God, who calls us to Himself through ways that may be hidden to us at the time, but which we see in the end to involve His loving pursuit and guiding hand,” said Bock. “In my case, this process required a transformation of my atheist worldview that effectively blinded me to spiritual reality. I was convinced that atheism was logical and empirical in ways that religion was not. In the end, God’s call in Christ was irresistible, although it took me a decade to realize it. In an instant, my view of truth, logic, human understanding, and the nature of human life was radically changed.”
“The Diary of a Reluctant Atheist” By David R Bock ISBN: 9798385001477 (softcover); 9798385001460 (hardcover); 9798385001484 (electronic) Available at C:\Users\davidbock\Library\Containers\com.apple.mail\Data\Library\Mail Downloads\38041AA3-90DB-4708-A52C-94C972BB0273\WestBow Press, Amazon and Barnes & Noble
About the author David R. Bock is a Rhodes Scholar who earned an advanced degree in economics from Oxford University. He has a career in international finance and development. To learn more, please visit C:\Users\davidbock\Library\Containers\com.apple.mail\Data\Library\Mail Downloads\38041AA3-90DB-4708-A52C-94C972BB0273\http://www.westbowpress.com/en/bookstore/bookdetails/848062-the-diary-of-a-reluctant-atheist.
Acquisition of Background Solutions created the foundation for an integrated solution to provide a faster hiring process for public safety agencies
EL SEGUNDO, Calif. , Sept. 3, 2024 /PRNewswire-PRWeb/ — NEOGOV, the leader in public safety and public sector human capital management software, today introduces Vetted, a background investigation software designed to streamline the hiring process for new public safety employees. This product launch is the result of the acquisition of Background Solutions and its Background Assistant product.
“Background Solutions has been developing its product and serving the needs of law enforcement agencies for over 15 years. We’ve combined their technology with NEOGOV’s deep understanding of the public sector and our comprehensive public safety platform, PowerDMS,” said Shane Evangelist, CEO of NEOGOV. “The end result is an enhanced version of the Background Assistant™ product, now known as Vetted, which integrates with our applicant tracking software, Insight.”
“We are excited that Background Assistant™ is now a part of NEOGOV’s product suite which I believe will help agencies vet officers more effectively and improve our public safety,” said Tom Ward, CEO of Background Solutions.
For many agencies today, the background investigation process is tedious and time-consuming. Traditional methods like paper or fillable forms lack audit trails and slow down the hiring process. Vetted digitally manages, tracks, and optimizes the background investigation and hiring process, enabling recruiters and background investigators to vet and hire candidates faster, gaining a competitive edge in the hiring process.
A single, secure platform enables applicants and investigators to share protected information while maintaining the integrity and compliance of each investigation. Candidates quickly upload documents and submit for review, which gives agencies the ability to view inconsistencies and identify potential issues early in the process.
“The background investigation process is a crucial component to the hiring process. This is particularly true in public safety as employees are responsible for the safety of citizens within their communities. With Vetted, public safety agencies can now save time and resources while having confidence that they are making the right hiring decisions,” said Denise Hemke, Chief Product Officer of NEOGOV.
Additionally, Vetted is easily configurable to an agency’s needs. Agencies define and document qualifiers and disqualifiers in the hiring process, then easily record why a candidate is approved or denied for hiring. The process is tracked throughout, saving background investigators time and resources.
“NEOGOV continues to broaden its government technology offering to address the most critical needs of its public sector customers and continue our mission to ‘serve the people who serve the people’,” continued Evangelist.
NEOGOV, a Carlyle and Warburg Pincus portfolio company serving more than 7,000 organizations, is the leading provider of an integrated HR, payroll, talent management and policy and compliance management solution for public sector HR, public safety and education. With NEOGOV, organizations are able to eliminate and automate systems and processes, so they can focus on what matters most – serving their core customers in a meaningful way. This results in improved productivity and engagement, time and cost savings, improved regulatory compliance, and reduced paper processes.
NEOGOVS’s platform includes PowerDMS, a public safety management platform which serves 5,500 police, fire and 911 customers. NEOGOV also offers NEOED, a one-stop shop HR suite for education.
Background Solutions LLC created Background Assistant™, a case management tool designed specifically for the law enforcement background investigator. Through years of training law enforcement background investigators from hundreds of police departments, Background Solutions has identified a collection of best practices.
Background Solutions has leveraged years of experience in law enforcement applicant screening to create a streamlined software solution that allows the background investigator to manage the vetting process.
The Foundation for Women’s Cancer (FWC), the official foundation of the Society of Gynecologic Oncology (SGO), proudly kicks off Gynecologic Cancer Awareness Month (GCAM) with its signature Move4Her fundraising campaign and annual drive to raise funds to end gynecologic (gyn) cancer. Throughout September, over 50 Move4Her teams are uniting people across the nation to Move Today for More Tomorrows, raising critical funds for gyn cancer research, education, and awareness. In 2024, the FWC is enhancing Move4Her with new tools, resources, and opportunities for individuals and teams to make a lasting impact and get involved to help eliminate gyn cancer for future generations.
Since 2020, patients, survivors, caregivers, allied health professionals, physicians, scientists, and others who have been or could be impacted by gyn cancer community have come together to drive a movement that has enabled research grants to discover and advance insights, prevention and treatment options. This year, more than 116,000 people will be diagnosed with a gyn cancer, which includes cervical, ovarian, uterine, vaginal, and vulvar cancers.
“Our goal is to end gyn cancers, and our first step is to ensure that everyone has all the prevention and treatment options possible, and to ultimately eliminate these diseases. The reality is that gyn cancer research and awareness has been underfunded – but together we can change that,” said Dr. Ginger J. Gardner, MD, Memorial Sloan Kettering Cancer Center, Chair, Foundation for Women’s Cancer. “Move4Her exemplifies what we can achieve together as a community. By participating, you are powering research, education, and awareness that lead to better health outcomes and more tomorrows.”
Move4Her has become a powerful force in the fight against gynecologic cancers, raising more than $2 million in its first four years and empowering thousands to take action. People are encouraged to build a team, join a team, or get involved as an individual, and making a difference has never been easier. By moving in whatever way inspires them —walking, running, dancing, or any form of activity—to help amplify the message and fund life-changing programs that offer hope for better outcomes today and for future generations.
The momentum surrounding the Move4Her campaign continues to grow, highlighted by the increased recognition among state and city municipalities, declaring September as GCAM. “Thanks to the advocacy of Move4Her volunteers, both Wisconsin and North Carolina have issued proclamations declaring September as GCAM. This month, we look forward to celebrating these recognitions and enjoying city skylines illuminated purple in Chicago and Charlotte, who also declared September as GCAM,” added Dr. Gardner.
Move4Her Walk and Celebration – Come Join Us!
This year’s Move4Her campaign will culminate in the Move4Her Walk and Celebration in Charlotte, North Carolina, on Saturday, September 28. This flagship event will bring together patients, caregivers, healthcare providers, and supporters in a day of unity and hope.
• 5:55-7:00 p.m.: Walk along the Little Sugar Creek Greenway
• 7:00-8:30 p.m.: Celebration at Lost Worlds Brewing (Charlotte location)
“I walk for those who can’t and for a future where fewer families experience the pain of this disease,” shared Janett Edelberg, a longtime supporter of the FWC and a passionate advocate of the Move4Her campaign. “The strength and support I’ve gained from the Move4Her community has been life-changing, and I want to inspire others to join us. This is my way of personally spreading awareness about all gynecologic cancers and the wonderful work that the Foundation does.”
With national attention and local community engagement, the FWC remains focused on driving critical research, increasing public education, and empowering survivors and families to advocate for better care and resources.
For more information on how to participate in the Move4Her campaign or to support FWC’s initiatives, please visit www.Move4Her.org.
Follow the FWC on its social media platforms Twitter, Instagram and Facebook for exciting updates throughout the year.
About the Foundation for Women’s Cancer
The Foundation for Women’s Cancer (FWC) is dedicated to eliminating gynecologic cancer by supporting research, education, and awareness for patients and their families. FWC is the official foundation of the Society of Gynecologic Oncology (SGO). To date, the FWC has awarded more than $11 million through 280 research grants and awards, and provides free patient education for all patients, advocates and community.
About The Society of Gynecologic Oncology
The Society of Gynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers. As a 501(c)(6) organization, SGO contributes to the advancement of women’s cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members, and collaborating with other domestic and international organizations. For more information, visit https://www.sgo.org.
Media Contact
Mary Conway, The Foundation for Women’s Cancer, 1 516-606-6545, [email protected]
